Lytic Therapy for Retained Traumatic Hemothorax: A Systematic Review and Meta-analysis.

Authors:
Brandon S Hendriksen
Brandon S Hendriksen
College of Medicine
Marcos T Kuroki
Marcos T Kuroki
University of Minnesota
Scott B Armen
Scott B Armen
East Tennessee State University
United States
Michael F Reed
Michael F Reed
University of Cincinnati College of Medicine
United States
Matthew D Taylor
Matthew D Taylor
University of Edinburgh
United Kingdom
Christopher S Hollenbeak
Christopher S Hollenbeak
The Pennsylvania State University
United States

Chest 2019 Apr 18;155(4):805-815. Epub 2019 Jan 18.

Department of Surgery, Pennsylvania State University College of Medicine, Hershey, PA; Department of Health Policy and Administration, College of Health and Human Development, Pennsylvania State University, University Park, PA; Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA.

Background: Intrapleural lytic therapy has been established as an important modality of treatment for many pleural disorders, including hemothorax and empyema. Retained traumatic hemothorax is a common and understudied subset of pleural disease. The current standard of care for retained traumatic hemothorax is operative management. The use of lytic therapy for avoidance of operative intervention in the trauma population has not been well established.

Methods: Randomized controlled trials (RCTs) and non-RCTs reporting operative intervention following the use of intrapleural lytic treatment for retained traumatic hemothorax were identified in the literature. The primary outcome was avoidance of surgery following treatment with any lytic agent. Meta-analysis was performed to pool the results of those studies. Subgroup analysis by type of lytic therapy and analysis of length of stay were also performed.

Results: One RCT and nine non-RCTs including 162 patients were pooled in the analysis. Avoidance of surgery following treatment with any lytic agent was found to be 87% (95% CI, 81%-92%). Tissue plasminogen activator resulted in 83% operative avoidance (95% CI, 71%-94%), and other, non-tissue plasminogen activator lytic agents resulted in 87% operative avoidance (95% CI, 82%-93%). The average length of stay for patients undergoing lytic therapy was 14.88 days (95% CI, 12.88-16.88).

Conclusions: Lytic therapy could reduce the need for operative intervention in trauma patients with retained traumatic hemothorax. RCTs are indicated to definitively evaluate the benefit of this approach.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2019.01.007DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
28 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter:
January 24, 2019, 4:01 pm EST
twitter
Twitter:
January 24, 2019, 3:11 pm EST

Publication Analysis

Top Keywords

lytic therapy
24
traumatic hemothorax
20
retained traumatic
20
operative intervention
12
lytic
10
intervention trauma
8
surgery treatment
8
plasminogen activator
8
lytic agent
8
intrapleural lytic
8
treatment lytic
8
length stay
8
avoidance surgery
8
hemothorax
6
operative
5
traumatic
5
therapy
5
avoidance
5
retained
5
95% 82%-93%
4

Similar Publications